logo

For the Inventor, By the Inventor

Yaffia, Israel

Elham Gazaleen-Mariee

This inventor holds 6 USPTO granted patents. Top assignee: Renopharm Ltd.. Active years: 2007-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elham Gazaleen-Mariee. Retrieved from https://idiyas.com/inventor/elham-gazaleen-mariee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 76(Granted Patents)


Company Filing History:

goldMedal6 out of 7 
 
Renopharm Ltd.
 patents

Years Active: 2007-2011

Loading Chart...
6 patents (USPTO):Explore Patents
1. 7968575 - Nitric oxide donors and uses thereof (2011-06-28),
2. 7579477 - Thiazole-based nitric oxide donors having alkyl substituent(s) and uses thereof (2009-08-25),
3. 7498445 - Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof (2009-03-03),
4. 7368577 - Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof (2008-05-06),
5. 7332513 - Thiazole-based nitric oxide donors having acyl substituent(s) and uses thereof (2008-02-19),
6. 7189750 - Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof (2007-03-13),

Title: Elham Gazaleen-Mariee: Innovator in Nitric Oxide Donors

Introduction

Elham Gazaleen-Mariee is a prominent inventor based in Yaffia, Israel. She has made significant contributions to the field of nitric oxide donors, with a total of 6 patents to her name. Her innovative work focuses on developing compounds that enhance medical treatments while minimizing tolerance development.

Latest Patents

Among her latest patents are two notable inventions. The first patent, titled "Nitric oxide donors and uses thereof," discloses novel NO-donating compounds. These compounds are designed to release nitric oxide in a manner that forms a naturally occurring metabolite, thereby preventing or decreasing the development of tolerance upon repetitive administration. The patent also outlines methods for preparing these compounds, as well as pharmaceutical compositions and medical devices that utilize them in treating various medical conditions.

The second patent, "Thiazole-based nitric oxide donors having alkyl substituent(s) and uses thereof," shares a similar focus on NO-donating compounds. It emphasizes the importance of creating compounds that release nitric oxide while forming a naturally occurring metabolite. This innovation aims to enhance the effectiveness of treatments and reduce tolerance development, along with detailing preparation methods and applications in medical devices.

Career Highlights

Elham Gazaleen-Mariee is currently associated with Renopharm Ltd., where she continues to advance her research and development efforts. Her work has positioned her as a key figure in the field of nitric oxide research, contributing to the understanding and application of these compounds in medicine.

Collaborations

Elham collaborates with notable colleagues, including Peter Assaf and Michael Naveh. Their combined expertise fosters an environment of innovation and progress in their research endeavors.

Conclusion

Elham Gazaleen-Mariee's contributions to the field of nitric oxide donors exemplify her dedication to advancing medical science. Her innovative patents and collaborative efforts continue to pave the way for new treatments and improved patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…